Analyst Consensus ?
ConsensusHold44 ratings
Bullish1125.0%
Neutral2965.9%
Bearish49.1%
FN2 Earnings Intelligence
The Travelers Companies, Inc. (TRV) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 5, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 26, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Oct 23, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 20, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 20, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 20, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 19, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 19, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 21, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 21, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 20, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 15, 2026 |
| TD Cowen | Sell | Hold | Downgrade | Jul 13, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 6, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 6, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 11, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 23, 2025 |
| Goldman Sachs | Buy | Sell | Upgrade | Jan 8, 2025 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Nov 21, 2024 |
| Roth MKM | Buy | Buy | Maintain | Oct 21, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 7, 2024 |
| William Blair | Market Perform | Outperform | Downgrade | Jun 28, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Apr 5, 2024 |
| CFRA | Buy | Hold | Upgrade | Apr 19, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jan 25, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 23, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 1, 2021 |
| Buckingham Research | Neutral | Neutral | Maintain | Jan 22, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Jan 22, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Sep 18, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jun 6, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 7, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 7, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Argus Research | Buy | Buy | Maintain | Apr 26, 2018 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Jan 26, 2018 |
| FBR Capital | Market Perform | Outperform | Downgrade | Feb 13, 2017 |
| Sandler O'Neill | Hold | Buy | Downgrade | Jul 28, 2014 |
| Guggenheim | Buy | Neutral | Upgrade | May 12, 2014 |
| Drexel Hamilton | Hold | Buy | Downgrade | Apr 24, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Apr 20, 2012 |
Upside is calculated against the persisted current price $409.25. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Analyst unavailable | $388 | $392.92 | -5.2% | Oct 20, 2026 |
| Mizuho Securities | Yaron Kinar | $371 | $385.45 | -9.3% | Oct 20, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $378 | $360.64 | -7.6% | Oct 7, 2026 |
| BMO Capital | Analyst unavailable | $379 | $368.5 | -7.4% | Jul 21, 2026 |
| Goldman Sachs | Alex Scott | $350 | $368.66 | -14.5% | Jul 20, 2026 |
| Truist Financial | Mark Hughes | $425 | $366.87 | +3.8% | Jul 20, 2026 |
| Raymond James | Gregory Peters | $430 | $368.98 | +5.1% | Jul 20, 2026 |
| Raymond James | Analyst unavailable | $307 | $368.98 | -25.0% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $290 | $336.83 | -29.1% | Jul 15, 2026 |
| Piper Sandler | Paul Newsome | $340 | $339.42 | -16.9% | Jul 13, 2026 |
| Truist Financial | Mark Hughes | $395 | $337.48 | -3.5% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $329 | $337.48 | -19.6% | Jul 10, 2026 |
| Barclays | Alex Scott | $295 | $303.9 | -27.9% | Jun 12, 2026 |
| Seaport Global | Analyst unavailable | $322 | $306.46 | -21.3% | May 26, 2026 |
| BMO Capital | Analyst unavailable | $314 | $305.76 | -23.3% | Apr 20, 2026 |
| Goldman Sachs | Robert Cox | $304 | $283.19 | -25.7% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $317 | $284.98 | -22.5% | Jan 7, 2026 |
| Mizuho Securities | Yaron Kinar | $317 | $290.64 | -22.5% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $313 | $284.97 | -23.5% | Oct 8, 2025 |
| Wells Fargo | Elyse Greenspan | $264 | $255.99 | -35.5% | Jul 10, 2025 |
| Morgan Stanley | Bob Huang | $269 | $274.54 | -34.3% | May 19, 2025 |
| Piper Sandler | Paul Newsome | $310 | $241.51 | -24.3% | Jan 24, 2025 |
| BMO Capital | Michael Zaremski | $270 | $259.7 | -34.0% | Oct 22, 2024 |
| JMP Securities | Meyer Shields | $273 | $259.7 | -33.3% | Oct 21, 2024 |
| Roth Capital | Harry Fong | $300 | $265.45 | -26.7% | Oct 21, 2024 |
| Wells Fargo | Elyse Greenspan | $256 | $265.45 | -37.4% | Oct 21, 2024 |
| Deutsche Bank | Cave Montazeri | $277 | $264.82 | -32.3% | Oct 18, 2024 |
| RBC Capital | Mark Dwelle | $273 | $264.82 | -33.3% | Oct 18, 2024 |
| Barclays | Alex Scott | $286 | $231.42 | -30.1% | Sep 4, 2024 |
| Piper Sandler | Paul Newsome | $207 | $203.48 | -49.4% | Jul 22, 2024 |
| Goldman Sachs | Alex Scott | $196 | $203.48 | -52.1% | Jul 22, 2024 |
| CFRA | Cathy Seifert | $225 | $203.48 | -45.0% | Jul 19, 2024 |
| Evercore ISI | David Motemaden | $236 | $203.48 | -42.3% | Jul 19, 2024 |
| Morgan Stanley | Bob Huang | $210 | $203.48 | -48.7% | Jul 19, 2024 |
| BMO Capital | Michael Zaremski | $240 | $203.48 | -41.4% | Jul 19, 2024 |
| J.P. Morgan | Jimmy Bhullar | $242 | $220.6 | -40.9% | Jul 19, 2024 |
| J.P. Morgan | Stephen Tusa | $95 | $213.07 | -76.8% | Jul 15, 2024 |
| RBC Capital | Mark Dwelle | $225 | $206.58 | -45.0% | Apr 18, 2024 |
| Goldman Sachs | Alex Scott | $202 | $206.58 | -50.6% | Apr 17, 2024 |
| CFRA | Cathy Seifert | $235 | $205.25 | -42.6% | Apr 17, 2024 |
| Morgan Stanley | Bob Huang | $214 | $206.06 | -47.7% | Apr 17, 2024 |
| UBS | Brian Meredith | $225 | $223.12 | -45.0% | Apr 17, 2024 |
| Raymond James | Gregory Peters | $185 | $159.68 | -54.8% | Jul 25, 2022 |
| RBC Capital | Mark Dwelle | $165 | $156.83 | -59.7% | Jul 22, 2022 |
| Wolfe Research | Charles Lederer | $156 | $163.15 | -61.9% | Jun 22, 2022 |
| Morgan Stanley | Analyst unavailable | $184 | $176.88 | -55.0% | Apr 20, 2022 |
| RBC Capital | Mark Dwelle | $190 | $184.86 | -53.6% | Apr 9, 2022 |
| Credit Suisse | Andrew Kligerman | $178 | $166.82 | -56.5% | Jan 30, 2022 |
| Jefferies | Yaron Kinar | $176 | $161.48 | -57.0% | Jan 6, 2022 |
| Bank of America Securities | Joshua Shanker | $152 | $156.96 | -62.9% | Oct 20, 2021 |
| UBS | Brian Meredith | $158 | $154.52 | -61.4% | Oct 11, 2021 |
Track every rating change on TRV the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.